Cayman Chemical

Executive Summary

Cayman Chemical, founded in 1980 and headquartered in Ann Arbor, Michigan, is a privately held manufacturer and supplier of high-quality biochemicals, assay kits, antibodies, recombinant proteins, and custom contract services. The company serves the life sciences and drug discovery markets, offering a comprehensive catalog of over 10,000 products and services including custom chemical synthesis, assay development, and screening. Its long-standing presence and diversified revenue streams from both product sales and contract services provide stability and consistent demand from academic, biotech, and pharmaceutical customers. While not a clinical-stage biotech, Cayman Chemical benefits from the broader growth in R&D spending and outsourcing trends, positioning it as a reliable partner in the preclinical research ecosystem.

Upcoming Catalysts (preview)

• Q2 2026Launch of New Assay Kits for Emerging Therapeutic Targets85% success
• Q3 2026Expansion of Custom Synthesis and Analytical Services Capacity80% success
• TBDStrategic Partnership or Distribution Agreement with a Major Pharma or CRO60% success